These inflammatory responses activate transcription factors implicated in cancer development and progression, including the signal transducer and activator of transcription 3 (STAT3) hypoxia-inducible factor 1 alpha (HIF1α), and nuclear factor-κB (NF-κB), whose activity controls the further production of inflammatory mediators [20]. Here, NFKB1 is linked to cancer.